QR kód

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors

Considering the unrecognised physio-pathological role of human carbonic anhydrase III (hCA III), a structure-based drug design was set up to identify the first-in-class potent and selective inhibitors of this neglected isoform. hCA III targeting was planned considering a unique feature of its active...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Simone Giovannuzzi, Alessandro Bonardi, Paola Gratteri, Alessio Nocentini, Claudiu T. Supuran
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis Group 2023-12-01
Edice:Journal of Enzyme Inhibition and Medicinal Chemistry
Témata:
On-line přístup:https://www.tandfonline.com/doi/10.1080/14756366.2023.2202360
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!